Bal Pharma Limited Share Price and Company Fundamentals
Last traded: Today at 9:59 AM
Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; herbal liver protective and antioxidant; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to approximately 30 countries. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.
Key Metrics
PE ratio
17.72
PB ratio
1.53
Dividend yield
1.60%
Beta
0.14
Market cap
₹1.21B
Enterprise value
₹2.67B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 986 |
| Website | https://www.balpharma.com |
| Mailing address | Lakshmi Narayan Complex 5th Floor 10/1, Palace Road Bengaluru 560052 India |
| Phone / Fax | 91 80 4137 9500 / 91 80 2235 4057 |
Dividends
Dividend yield
1.60%
Dividend amount
₹1.20
Payout ratio
27.97%
5Y Avg. yield
-%
Bal Pharma Limited paid ₹1.20 dividend and the ex-dividend date was 18 Sep 2025.The dividend payout ratio is 27.97%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BALPHARMA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Bal Pharma Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Shailesh Dheerajmal Siroya | MD & Executive Director | 59 | |
| Mr. Daddanala Venkat Bharath Bhushan | Chief Financial Officer | 36 | |
| Ms. Archana Dubey Mitra | Chief Operating Officer | 51 | |
| Mr. Abdul Basith | Company Secretary & Compliance Officer | ||
| Mr. Himesh Virupakshaya | Whole Time Director | 64 | |
| Mr. Ravindra Kumar Kothari | Deputy GM of Internal Audit, Legal and Compliances & Non-Executive and Non-Independent Director | 70 | |
| Mr. D. L. Bhat | Assistant Vice President of Sales & Marketing | 62 | |
| N Subrahmanyeswara Rao | Senior General Manager | 53 | |
| Ezaz Kaseem Azmi | General Manager | 43 | |
| Bidyut Kumar Bhattacharrya | General Manager of Purchase | 49 |
Profitability and management effectiveness
Profit margin
2.63%
Operating margin
7.20%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Bal Pharma Limited is 1.21B and its enterprise value is 2.67B. The enterprise value to revenue ratio of BALPHARMA is 0.86. The enterprise value to EBITDA ratio of BALPHARMA is 11.07.
The BALPHARMA's stocks Beta value is 0.14 making it 86% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Bal Pharma Limited (NSE:BALPHARMA) Frequently Asked Questions
1. What is Bal Pharma Limited's Stock Symbol?
Bal Pharma Limited trades on NSE under the ticker symbol "BALPHARMA".
2. What is Bal Pharma Limited's stock price today?
One share of BALPHARMA stock can currently be purchased for approximately ₹76.03.
3. How can I contact Bal Pharma Limited?
Bal Pharma Limited's mailing address is Lakshmi Narayan Complex 5th Floor 10/1, Palace Road Bengaluru 560052 India. The company can be reached via phone at 91 80 4137 9500.
4. What is Bal Pharma Limited's official website?
The official website of Bal Pharma Limited is https://www.balpharma.com.